Completed NA INTERVENTIONAL NCT00838721

Evaluation of Pascal Laser Trabeculoplaty (PLT)

Prospective Evaluation of the Efficacy of Pascal Trabeculoplasty: A Pilot Study

Sponsor: OptiMedica Corporation

Conditions Ocular Hypertension Open Angle Glaucoma

Updated 5 times since 2017 Last updated: Oct 12, 2016 Started: Mar 31, 2008 Primary completion: Mar 31, 2010 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00838721, this NA trial focuses on Ocular Hypertension and Open Angle Glaucoma and remains completed. Sponsored by OptiMedica Corporation, it has been updated 5 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

OptiMedica Corporation
Santa Clara Valley Health & Hospital System

Data source: Santa Clara Valley Health & Hospital System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Jose, United States